QVT Associates GP LLC, 10% Owner at Urovant Sciences Ltd. (UROV), bought 39,660 shares at $8.52 ($326K) on 2019-05-21, disclosed to the SEC on 2019-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.52 | 9,995 | $85K | 26.1% |
| 2 | $8.52 | 9,995 | $85K | 26.1% |
| 3 | $8.06 | 5,033 | $41K | 12.4% |
| 4 | $8.06 | 5,033 | $41K | 12.4% |
| 5 | $7.76 | 4,802 | $37K | 11.4% |
| 6 | $7.76 | 4,802 |
| $37K |
| 11.4% |
| Total | $8.22 avg | 39,660 | $326K | 100% |
| Filing → |
| UROV | BUY | 2019-06-03 | $278K | — | Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-20 | $326K | — | Filing → |